Obtenez une réponse de ce recruteur
Votre CV et votre lettre de motivation, adaptés exactement à ce que l’employeur recherche.
Planet Pharma in Singapore partners with a major biomedical organisation building a translational drug discovery platform focused on nucleic acid medicines. The successful candidate will join as Scientist or Senior Scientist in Computational Biology and Target Discovery to identify, prioritise and validate novel therapeutic targets for cardiometabolic diseases.
This role integrates human genetics, multi-omics and disease biology to determine targets for siRNA, ASO and related RNA modalities,
Location: Singapore
Employment Type: Full-time, Permanent
Relocation: International candidates welcomed
We are partnering with a major Singapore-based biomedical research and therapeutics organisation that is building an ambitious, highly translational drug discovery platform focused on the next generation of nucleic acid medicines.
As part of continued investment into its cardiovascular and metabolic disease portfolio, the organisation is seeking an experienced Scientist / Senior Scientist in Computational Biology and Target Discovery.
This is not a traditional bioinformatics support position. The successful scientist will play a central role in identifying, prioritising and validating novel therapeutic targets, integrating human genetics, multi-omics and disease biology to determine which targets should progress into experimental drug discovery.
The focus will be on MASH, obesity and related cardiometabolic diseases, with an emphasis on identifying targets suitable for therapeutic modulation using siRNA, ASO and other nucleic acid approaches.
The successful candidate will ideally bring:
Candidates do not necessarily need to tick every box, but experience in several of the following areas would be highly relevant:
This is an opportunity to join a significant and well-funded therapeutics initiative in Singapore at an important stage of its development.
Rather than simply generating computational analyses, the successful candidate will have the opportunity to influence which biological targets become future drug discovery programs and work directly alongside experimental scientists to translate human data into therapeutic hypotheses.
The wider platform combines human disease biology, computational science, oligonucleotide chemistry, translational pharmacology and drug development, creating an environment where computational discoveries can be tested and progressed toward therapeutic development.
The organisation is conducting a global search, with international relocation considered for exceptional candidates.